Former 168-pound titleholder Caleb Plant (23-2, 14 KOs) will headline Saturday's PBC card (8 p.m. ET, Prime Video) in a 12-round bout against the hard-charging Armando Resendiz (15-2, 11 KOs).

NORTHAMPTON, MA / ACCESS Newswire / May 15, 2025 / "Living with primary biliary cholangitis (PBC) can be an isolating experience," explains Dilek, a mother of two from Germany who suffers from the ...

Viral infections can sometimes cause itchy or painful rashes. Here’s a breakdown of the most common viral skin rashes, what they look like, and how to deal with them.

FOSTER CITY, Calif., May 09, 2025--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today presented new data from its Phase 2b VANTAGE study at the European Association for the Study of ...

Linerixibat, an investigational oral ileal bile acid transporter (IBAT) inhibitor, improved cholestatic pruritus in patients with primary biliary cholangitis (PBC), the randomized phase III ...

Dermatologists break down the most common circular rashes that aren’t ringworm, including hives, lupus, and atopic dermatitis. See pictures here.

Primary biliary cholangitis (PBC) is an autoimmune disorder that leads to the destruction of bile ducts within the liver. As more bile ducts become lost and damaged, bile acids build up within the ...

Iqirvo is usually taken with another medicine for PBC called ursodeoxycholic acid. ... vomiting, constipation, heartburn, dry mouth, muscle pain or injury, rash, and joint stiffness.

The ongoing, global phase 3 GLISTEN study (ClinicalTrials.gov Identifier: NCT04950127) enrolled 238 adult PBC patients with moderate to severe pruritus who were receiving stable doses of guideline ...

Mirum Pharmaceuticals is running a phase 2 trial to test another IBAT inhibitor, volixibat, as a treatment for itch associated with PBC. GSK itching clinical trial data Clinical Data liver disease ...

Her PBC has developed into cirrhosis, and she also has arthritis and thyroid disease. The itching drives her nuts sometimes too, she told me. But she does not dwell on it either.

Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Lastly, chenodiol, has been evaluated in a Phase 3 clinical study, ...